ANDREASI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 2.228
NA - Nord America 2.148
AS - Asia 1.902
SA - Sud America 273
Continente sconosciuto - Info sul continente non disponibili 155
AF - Africa 41
OC - Oceania 4
Totale 6.751
Nazione #
US - Stati Uniti d'America 2.034
RU - Federazione Russa 1.271
CN - Cina 629
SG - Singapore 619
IT - Italia 318
HK - Hong Kong 249
BR - Brasile 219
SE - Svezia 166
VN - Vietnam 153
DE - Germania 115
FR - Francia 87
GB - Regno Unito 79
CA - Canada 66
BD - Bangladesh 60
IN - India 59
FI - Finlandia 56
JP - Giappone 31
ES - Italia 29
NL - Olanda 24
AR - Argentina 22
MX - Messico 20
PL - Polonia 19
AT - Austria 17
PK - Pakistan 13
TR - Turchia 13
ZA - Sudafrica 12
IE - Irlanda 11
NP - Nepal 11
EC - Ecuador 9
ID - Indonesia 8
MA - Marocco 8
PH - Filippine 8
CO - Colombia 7
IQ - Iraq 7
JM - Giamaica 6
SA - Arabia Saudita 6
CR - Costa Rica 5
KE - Kenya 5
LT - Lituania 5
TN - Tunisia 5
UA - Ucraina 5
UZ - Uzbekistan 5
AU - Australia 4
BE - Belgio 4
BO - Bolivia 4
CH - Svizzera 4
IL - Israele 4
MD - Moldavia 4
MY - Malesia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
HN - Honduras 3
JO - Giordania 3
KR - Corea 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TW - Taiwan 3
VE - Venezuela 3
AO - Angola 2
AW - Aruba 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
KZ - Kazakistan 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
IS - Islanda 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.596
Città #
Singapore 370
Ashburn 358
Dallas 260
Moscow 251
Hong Kong 241
San Jose 215
Beijing 127
Shanghai 122
Council Bluffs 116
New York 113
Milan 95
Los Angeles 92
Hefei 67
Ho Chi Minh City 53
Lauterbourg 53
Santa Clara 49
Boardman 41
São Paulo 37
Hanoi 36
Orem 36
Munich 31
London 28
Helsinki 27
Lawrence 26
Princeton 26
Tokyo 26
Montreal 24
Rome 24
Nuremberg 22
Turku 22
Washington 22
Chennai 20
Toronto 19
The Dalles 18
Chicago 17
Cesano Boscone 16
Brooklyn 15
Columbus 15
Frankfurt am Main 15
Atlanta 14
Boston 14
Manchester 14
Omaha 14
Phoenix 13
Poplar 13
San Francisco 13
Warsaw 13
Denver 12
Seattle 12
Dublin 11
Guangzhou 11
Falkenstein 10
Houston 10
Mexico City 10
Buffalo 9
Mumbai 9
Stockholm 9
Amsterdam 8
Johannesburg 8
Kathmandu 8
Romagnano Sesia 8
Ankara 7
Da Nang 7
New Delhi 7
Rio de Janeiro 7
Valencia 7
Dhaka 6
Jinan 6
Lappeenranta 6
Pune 6
Barnet 5
Belo Horizonte 5
Brescia 5
Charlotte 5
Haiphong 5
Las Vegas 5
Nairobi 5
Philadelphia 5
Tabira 5
The Bronx 5
Turin 5
Baie-D'Urfé 4
Biên Hòa 4
Brasília 4
Jeddah 4
Olgiate Olona 4
Ottawa 4
Pittsburgh 4
Portland 4
San José 4
Shenzhen 4
Sydney 4
São Gonçalo 4
Tashkent 4
Thái Bình 4
Verona 4
Vienna 4
Wroclaw 4
Zhengzhou 4
Bologna 3
Totale 3.577
Nome #
ROLE OF CHROMOGRANIN A-DERIVED FRAGMENTS AND OTHER BIOMARKERS IN PANCREATIC NEOPLASMS: FOCUS ON NEUROENDOCRINE TUMORS 192
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 187
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 181
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 165
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 161
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 152
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 145
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 133
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 132
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 132
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 123
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 122
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 121
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 118
Could Glycated Hemoglobin be Leakage Predictor in Sleeve Gastrectomy? A Retrospective Observational Study on 4233 Patients 115
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 115
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 112
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 111
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 110
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 107
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 106
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 105
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 104
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 103
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 103
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 102
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 102
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 101
Non functional pancreatic neuroendocrine tumors 101
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 101
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 100
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 100
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 98
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 97
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 96
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 95
New Surgical Strategies 93
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 90
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 90
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 89
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 88
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 88
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 88
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 87
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 84
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors 84
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysis 81
Prognostic significance of nodal micrometastases of non-functioning pancreatic neuroendocrine tumours 79
Local treatment for focal progression in metastatic neuroendocrine tumors 79
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting 79
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) 77
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 73
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 72
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 70
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 70
Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 68
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) 66
Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis 66
Prognostic role of examined and positive lymph nodes after distal pancreatectomy for non-functioning neuroendocrine neoplasms 65
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 62
Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis 62
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms 57
Update on gastroenteropancreatic neuroendocrine tumors 56
Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors 55
Gender and Age as Preoperative Predictors of Early Disease Progression in Patients Undergoing Surgery for Pancreatic Neuroendocrine Tumors with Liver Metastases 53
Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach 53
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 52
Reply to Letter to the Editor: Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 50
Preoperative predictors of new-onset diabetes mellitus following distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors 49
Clinico-pathological features and prognosis of mixed-IPMNs with a focal involvement of the main pancreatic duct 10
Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor 5
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours 5
Surgical management of pancreatic neuroendocrine tumours 4
Procedure-specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors 4
Totale 6.751
Categoria #
all - tutte 32.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 1 1 6 4 2 10 1 6 2 2 3
2022/2023303 59 50 23 19 12 44 26 29 17 8 8 8
2023/2024533 19 25 72 54 61 111 6 48 4 13 30 90
2024/20251.307 119 45 47 52 65 125 253 171 138 88 95 109
2025/20264.279 284 241 243 526 428 155 370 333 1.134 245 173 147
2026/2027269 113 156 0 0 0 0 0 0 0 0 0 0
Totale 6.751